Investigating the factors proposed in oral lichen planus malignant transformation: A literature review

Lichen planus is a chronic inflammatory disease that affects about 1% of the world's population. The World Health Organization has included oral lichen planus among potentially malignant disorders. Identification of reliable biomarkers for the diagnosis of malignant transformation may play a unique role in the development of standard screening and improvement of follow‐up in patients with oral precancerous lesions. It is currently assumed that the molecular pathways controlling growth, maturation, proliferation, and apoptosis in epithelial cells may play an important role in the process of transformation into malignancy.

[1]  N. Rezaei,et al.  Interleukin-10 in Oral Lichen Planus – Review and Meta-Analysis , 2020, Current Immunology Reviews.

[2]  A. Rich,et al.  Malignant transformation in oral lichen planus and lichenoid lesions: a 14-year longitudinal retrospective cohort study of 829 patients in New Zealand. , 2020, Oral surgery, oral medicine, oral pathology and oral radiology.

[3]  O. Shaker,et al.  Assessment of miR-155 in Saliva of Oral Lichen Planus Patients as a Potential Biomarker of Malignant Transformation Before and After Topical Corticosteroid Therapy , 2020 .

[4]  Ahmad Bazli Ramzi,et al.  The role of Candida albicans candidalysin ECE1 gene in oral carcinogenesis. , 2020, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[5]  H. Mohammadpour,et al.  Association of MAPK and its regulatory miRNAs (603, 4301, 8485, and 4731) with the malignant transformation of oral lichen planus , 2019, Molecular Biology Reports.

[6]  M. Caraglia,et al.  Salivary mir-27b expression in oral lichen planus patients: a series of cases and a narrative review of litterature. , 2019, Current topics in medicinal chemistry.

[7]  Qianming Chen,et al.  Role of miR-155 in immune regulation and its relevance in oral lichen planus , 2018, Experimental and therapeutic medicine.

[8]  M. Neagu,et al.  Inflammation: A key process in skin tumorigenesis , 2018, Oncology letters.

[9]  E. Amr,et al.  Evaluation of the role of YKL-40 and interleukin-8 (IL-8) as biomarkers for malignant transformation in oral lichen planus , 2018 .

[10]  T. Omar,et al.  EXPRESSION OF INTERLEUKIN-10 AND ITS VALUE AS A POTENTIAL MARKER IN ORAL SQUAMOUS CELL CARCINOMA , 2018 .

[11]  E. M. Kogawa,et al.  Oral lichen planus and malignant transformation: The role of p16, Ki-67, Bub-3 and SOX4 in assessing precancerous potential , 2018, Experimental and therapeutic medicine.

[12]  O. Shaker,et al.  Evaluating the accuracy of microRNA27b and microRNA137 as biomarkers of activity and potential malignant transformation in oral lichen planus patients , 2018, Archives of Dermatological Research.

[13]  X. Li,et al.  Study on expression of p16 and human papillomavirus 16 and 18 (E6) in OLP and its malignant transformation. , 2017, Pathology, research and practice.

[14]  A. Abushouk,et al.  Correlation between tissue expression of microRNA-137 and CD8 in oral lichen planus , 2018, Clinical Oral Investigations.

[15]  L. Munn.  Cancer and inflammation , 2017, Wiley interdisciplinary reviews. Systems biology and medicine.

[16]  Lanying Sun,et al.  MicroRNA‐137 suppresses tongue squamous carcinoma cell proliferation, migration and invasion , 2016, Cell proliferation.

[17]  F. Agha-Hosseini,et al.  Evaluation of Potential Risk Factors that contribute to Malignant Transformation of Oral Lichen Planus: A Literature Review. , 2016, The journal of contemporary dental practice.

[18]  S. Challacombe,et al.  Image-based DNA ploidy analysis aids prediction of malignant transformation in oral lichen planus. , 2016, Oral surgery, oral medicine, oral pathology and oral radiology.

[19]  G. Suganya,et al.  Survivin expression in oral lichen planus: Role in malignant transformation , 2016, Journal of oral and maxillofacial pathology : JOMFP.

[20]  A. Mahdi,et al.  Association of interleukin-10 (A1082G) gene polymorphism with oral squamous cell carcinoma in north Indian population , 2016, Journal of Genetics.

[21]  M. A. O. Ignacio,et al.  How to cite this article , 2016 .

[22]  F. Agha-Hosseini,et al.  Unstimulated salivary p53 in patients with oral lichen planus and squamous cell carcinoma. , 2015, Acta medica Iranica.

[23]  R. F. D. de Amorim,et al.  In situ carcinoma developed over oral lichen planus: a case report with analysis of BUB3, p16, p53, Ki67 and SOX4 expression , 2015, Journal of applied oral science : revista FOB.

[24]  A. Al-Asmari,et al.  TNF-α, TNF-β and IL-10 gene polymorphism and association with oral lichen planus risk in Saudi patients , 2015, Journal of applied oral science : revista FOB.

[25]  G. Shailaja,et al.  Estimation of malignant transformation rate in cases of oral epithelial dysplasia and lichen planus using immunohistochemical expression of Ki-67, p53, BCL-2, and BAX markers , 2015, Dental research journal.

[26]  Yi-Hsin Yang,et al.  TGF‐β1 and IL‐10 single nucleotide polymorphisms as risk factors for oral cancer in Taiwanese , 2015, The Kaohsiung journal of medical sciences.

[27]  Yi-Hsin Yang,et al.  Role of cytokine gene (interferon‐γ, transforming growth factor‐β1, tumor necrosis factor‐α, interleukin‐6, and interleukin‐10) polymorphisms in the risk of oral precancerous lesions in Taiwanese , 2014, The Kaohsiung journal of medical sciences.

[28]  E. Otero-Rey,et al.  Malignant transformation of oral lichen planus by a chronic inflammatory process. Use of topical corticosteroids to prevent this progression? , 2014, Acta odontologica Scandinavica.

[29]  Xiaolong Wang,et al.  Expression of CD163, interleukin-10, and interferon-gamma in oral squamous cell carcinoma: mutual relationships and prognostic implications. , 2014, European journal of oral sciences.

[30]  L. Ding,et al.  Upregulation of a potential prognostic biomarker, miR-155, enhances cell proliferation in patients with oral squamous cell carcinoma. , 2014, Oral surgery, oral medicine, oral pathology and oral radiology.

[31]  Zengtong Zhou,et al.  Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus. , 2013, Annals of diagnostic pathology.

[32]  A. Majorana,et al.  Clinicopathological features and malignant transformation of oral lichen planus: A 12-years retrospective study , 2013, Acta odontologica Scandinavica.

[33]  Christine Unger,et al.  In vitro cell migration and invasion assays. , 2013, Mutation research.

[34]  F. Agha-Hosseini,et al.  p53 as a neoplastic biomarker in patients with erosive and plaque like forms of oral lichen planus. , 2013, The journal of contemporary dental practice.

[35]  Wan-Yu Lo,et al.  miR-27b-regulated TCTP as a novel plasma biomarker for oral cancer: from quantitative proteomics to post-transcriptional study. , 2012, Journal of proteomics.

[36]  M. Mravak-Stipetić,et al.  The frequency and malignant transformation rate of oral lichen planus and leukoplakia--a retrospective study. , 2012, Collegium antropologicum.

[37]  W. Liu,et al.  A retrospective clinicopathological study on oral lichen planus and malignant transformation: Analysis of 518 cases , 2012, Medicina oral, patologia oral y cirugia bucal.

[38]  W. Morrison.  Inflammation and cancer: a comparative view. , 2012, Journal of veterinary internal medicine.

[39]  M. Tettamanti,et al.  Oral lichen planus and malignant transformation: a longitudinal cohort study. , 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[40]  M. Filho,et al.  Prevalence and risk indicators of oral mucosal lesions in an urban population from South Brazil. , 2011, Oral diseases.

[41]  V. Prasad,et al.  Expression of p53 protein and ki-67 antigen in oral premalignant lesions and oral squamous cell carcinomas: An immunohistochemical study , 2011, National journal of maxillofacial surgery.

[42]  M. Neagu,et al.  Immune-related biomarkers for diagnosis/prognosis and therapy monitoring of cutaneous melanoma , 2010, Expert review of molecular diagnostics.

[43]  F. Agha-Hosseini,et al.  Hepatitis C Virus and Lichen Planus: The Real Association , 2010, Hepatitis monthly.

[44]  W. Liu,et al.  Podoplanin and ABCG2: Malignant Transformation Risk Markers for Oral Lichen Planus , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[45]  T. Wang,et al.  Chronic inflammation, the tumor microenvironment and carcinogenesis , 2009 .

[46]  S Gandolfo,et al.  Course of oral lichen planus: a retrospective study of 808 northern Italian patients. , 2009, Oral diseases.

[47]  F. Agha-Hosseini,et al.  IMMUNOHISTOCHEMISTRY ANALYSIS OF P53 AND KI-67 PROTEINS IN ORAL LICHEN PLANUS AND NORMAL ORAL MUCOSA , 2009 .

[48]  I. van der Waal,et al.  Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. , 2009, Oral oncology.

[49]  C. Healy,et al.  The reported prevalence of oral lichen planus: a review and critique. , 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[50]  J. Li,et al.  Genetic variation in interleukin-10 gene and risk of oral cancer. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[51]  E. Nkenke,et al.  The interleukin-10 (-1082A/G) polymorphism is strongly associated with increased risk for oral squamous cell carcinoma. , 2008, Anticancer research.

[52]  R. Zain,et al.  Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. , 2007, Journal of oral science.

[53]  M. Gonzalez-Moles,et al.  Cell cycle regulating mechanisms in oral lichen planus: molecular bases in epithelium predisposed to malignant transformation. , 2006, Archives of oral biology.

[54]  J. Gil-Montoya,et al.  Apoptosis and cell cycle arrest in oral lichen planus Hypothesis on their possible influence on its malignant transformation. , 2005, Archives of oral biology.

[55]  M. Fan,et al.  A clinical study of 674 patients with oral lichen planus in China. , 2005, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[56]  N. Johnson,et al.  Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case-control study in Southern England. , 2004 .

[57]  I. Waal,et al.  Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications , 2003 .

[58]  G. Palestro,et al.  Sequential immunohistochemical p53 expression in biopsies of oral lichen planus undergoing malignant evolution. , 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[59]  N. McLean,et al.  Malignant transformation of oral lichen planus. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[60]  A. Markopoulos,et al.  Malignant potential of oral lichen planus; a follow-up study of 326 patients. , 1997, Oral oncology.

[61]  M. Carrozzo,et al.  An atypical verrucous carcinoma of the tongue arising in a patient with oral lichen planus associated with hepatitis C virus infection. , 1997, Oral oncology.

[62]  Y. Konttinen,et al.  Expression of c-erbB-2 protein in keratinocytes of oral mucosal lichen planus and subsequent squamous cell carcinoma. , 1996, European journal of oral sciences.

[63]  S Silverman,et al.  A prospective follow-up study of 570 patients with oral lichen planus: persistence, remission, and malignant association. , 1985, Oral surgery, oral medicine, and oral pathology.